Latest Financials News

Macarthur Minerals Limited has issued a replacement prospectus for a renounceable entitlement offer aiming to raise approximately AUD 2 million, fully underwritten by Gold Valley Yilgarn Pty Ltd. The offer includes free attaching options and supports the company’s exploration and operational funding needs.

Terra Metals has raised $4 million through a strategic placement, attracting heavyweight investors to accelerate exploration at its Dante Project in Western Australia.

Western Gold Resources has voluntarily suspended its shares from trading as it prepares to disclose details of a significant agreement and respond to an ASX price query.

ASX Limited has finalised the sale of its investment in Digital Asset Holdings for $57 million, securing a substantial pre-tax gain that will bolster its FY25 financial results.

Brookfield Infrastructure Partners has sold nearly a quarter of its stake in Dalrymple Bay Infrastructure, reducing its holding but remaining the largest shareholder. This move boosts DBI's free float and could pave the way for its inclusion in the S&P ASX 200 index.

Minbos Resources reports strong 2024-25 field trial results for its phosphate fertilizer PRIMEIRO™ in Angola, while expanding its product range with PRIMEIRO PLUS+, a blended NPKS solution tailored to local soils and crops.

Empire Energy Group has successfully closed and upsized its Share Purchase Plan to $7 million, raising crucial funds to advance its Beetaloo Basin projects. The capital raise strengthens the company’s cash position ahead of key operational milestones.

The Reject Shop Limited has announced a special fully franked dividend of AUD 0.77 per share, contingent on the approval of its acquisition by Dollarama Inc. Key dates for the dividend include an ex-dividend date of 4 July and payment on 14 July 2025.

ASPI Isotopes Inc. has proposed a scheme to acquire all Renergen shares at a 41.3% premium, aiming to create a global critical materials powerhouse. The deal, subject to shareholder and regulatory approval, will delist Renergen from multiple exchanges.

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.

Accent Group reports a modest decline in like-for-like sales and margin compression in the second half of FY25, setting full-year EBIT guidance between $108 million and $111 million.

Challenger Limited has welcomed APRA’s consultation on new capital settings for annuity products, highlighting the potential for regulatory reforms to boost innovation and growth in Australia’s retirement income sector.